Market Watch: Hims & Hers Health Inc (HIMS)’s Noteworthy Drop, Closing at 22.15

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $22.15, down -1.07% from its previous closing price of $22.39. In other words, the price has decreased by -$1.07 from its previous closing price. On the day, 11.82 million shares were traded. HIMS stock price reached its highest trading level at $22.52 during the session, while it also had its lowest trading level at $20.92.

Ratios:

To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 23.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 91.67. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on May 22, 2024, Downgraded its rating to Neutral and sets its target price to $20 from $16 previously.

On April 16, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $17 to $15.

On April 10, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.Canaccord Genuity initiated its Buy rating on April 10, 2024, with a $20 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 20 ’24 when Dudum Andrew sold 45,755 shares for $22.97 per share. The transaction valued at 1,051,087 led to the insider holds 33,502 shares of the business.

Chi Michael sold 7,500 shares of HIMS for $183,750 on Jun 20 ’24. The Chief Commercial Officer now owns 185,326 shares after completing the transaction at $24.50 per share. On Jun 18 ’24, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 25,549 shares for $23.59 each. As a result, the insider received 602,701 and left with 185,326 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 4757509632 and an Enterprise Value of 4565742592. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.96 while its Price-to-Book (P/B) ratio in mrq is 13.79. Its current Enterprise Value per Revenue stands at 4.759 whereas that against EBITDA is 877.521.

Stock Price History:

Over the past 52 weeks, HIMS has reached a high of $25.74, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is 36.01%, while the 200-Day Moving Average is calculated to be 101.95%.

Shares Statistics:

It appears that HIMS traded 9.27M shares on average per day over the past three months and 11158750 shares per day over the past ten days. A total of 205.10M shares are outstanding, with a floating share count of 150.62M. Insiders hold about 29.77% of the company’s shares, while institutions hold 47.18% stake in the company. Shares short for HIMS as of 1715731200 were 22125254 with a Short Ratio of 2.28, compared to 1713139200 on 17468335. Therefore, it implies a Short% of Shares Outstanding of 22125254 and a Short% of Float of 11.76.

Most Popular